Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,660.00
-90.00 (-3.27%)
At close: Oct 8, 2026

Aligned Genetics Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,6422,9114,1283,2362,3335,542
Depreciation & Amortization
694.22608.95575.74631.38650.38538.59
Loss (Gain) From Sale of Assets
-10.78-10.78--4.5--13.94
Loss (Gain) From Sale of Investments
172.32178.267.44-34.04591.23-1,686
Loss (Gain) on Equity Investments
--29.26181.79-80.52178.96
Stock-Based Compensation
19.87-----
Provision & Write-off of Bad Debts
58.8820.68-2.79-0.55-11.882.97
Other Operating Activities
-1,082537.39-739.87487.38417.5399.1
Change in Accounts Receivable
-301.29193.5582.54-1,214717.6-2,025
Change in Inventory
-351.46-813.88-119.94-55.66-1,407-337.39
Change in Accounts Payable
-305.9150.29-219.9814.31-53.191,017
Change in Unearned Revenue
---18.919.86--
Change in Other Net Operating Assets
-551.27-66.84-699.56-452.6-1,084-1,409
Operating Cash Flow
3,0303,6053,0652,8492,222135.97
Operating Cash Flow Growth
-16.12%17.61%7.61%28.18%1534.52%281.17%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-10,929-11,065-257.69-878.54-2,001-3,307
Sale of Property, Plant & Equipment
---12.98-32.25
Sale (Purchase) of Intangibles
-72.81-45.15-145.75-1.87-2.23-
Sale (Purchase) of Real Estate
-5,997-5,997----1,557
Investment in Securities
-21,5807,500-7,0111,5024,000248.18
Other Investing Activities
223.94232.27282.35655.49555.69916.01
Investing Cash Flow
-15,719-9,068-7,5451,2902,537-3,668

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----978
Long-Term Debt Issued
-12,0002,400--3,900
Total Debt Issued
12,00012,0002,400--4,878
Short-Term Debt Repaid
------978
Long-Term Debt Repaid
--270.9-4,130-192.75-176.33-267.41
Total Debt Repaid
-271.96-270.9-4,130-192.75-176.33-1,245
Net Debt Issued (Repaid)
11,72811,729-1,730-192.75-176.333,633
Issuance of Common Stock
0-----
Repurchase of Common Stock
--997.53----
Other Financing Activities
70-0----
Financing Cash Flow
11,79810,732-1,730-192.75-176.333,633

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-174.09-790.141,422284.86-24.31397.42
Miscellaneous Cash Flow Adjustments
-0-0----0
Net Cash Flow
-1,0654,479-4,7884,2314,559498.31

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7,899-7,4592,8081,970220.98-3,171
Free Cash Flow Growth
--42.52%791.50%--
Free Cash Flow Margin
-48.87%-46.58%17.79%12.95%1.61%-26.96%
Free Cash Flow Per Share
-560.10-528.42195.20137.0115.37-220.57
Levered Free Cash Flow
-10,600-9,1161,112947.12-388.58-2,676
Unlevered Free Cash Flow
-10,433-9,0511,2171,081-284.86-2,658

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
221.0785.76138.56190.05165.328.88
Cash Income Tax Paid
206.2130.97122.8916949.25113.39
Change in Working Capital
-1,464-640.76-932.52-1,649-1,677-4,526